What OATS and mosaicplasty actually do

Both OATS and mosaicplasty solve the same problem — a hole in the knee's load-bearing surface — using the same core idea: take a cylinder of healthy bone and cartilage from a quiet corner of the same knee and press it into the damaged site. Everything happens in a single operation; there is no laboratory stage, no second procedure.

The two techniques differ mainly in how many plugs are used. OATS transfers one larger cylinder, typically 8–10 mm in diameter, which suits compact focal defects. Mosaicplasty arranges several smaller plugs — usually 6–10 mm each — side by side in a mosaic pattern, allowing the surgeon to cover a wider damaged area than a single plug could fill.

The donor site is a peripheral, lower-stress zone of the same knee, generally the edge of the femoral condyle where it sits outside the main weight-bearing track. No separate joint is involved, and no donor bone or cadaver tissue is needed.

The critical structural point is what kind of tissue arrives at the repair site. The transplanted plugs carry genuine hyaline cartilage — the dense, slippery tissue that lines every healthy joint surface and is built to absorb decades of compressive loading. The main alternative marrow-stimulation technique, microfracture, produces fibrocartilage: a scar-like tissue with lower stiffness and poorer wear resistance that tends to break down under repeated joint loading. Because OATS and mosaicplasty transplant the real thing rather than stimulating a substitute, the repaired surface is structurally closer to what was there before injury.

Who is the right patient for this procedure

Strong candidates share several overlapping features, and understanding them helps clarify why not every knee cartilage problem leads to this procedure.

The ideal patient is a physically active adult, generally under 40–50 years of age, with a focal, full-thickness defect — ICRS grade III or IV — that has not improved with a reasonable course of conservative management such as physiotherapy or injection therapy. "Focal" matters here: this is a defined, contained lesion with intact surrounding cartilage, not the kind of diffuse arthritic change that affects multiple compartments.

Joint mechanics must also be sound. An intact or reconstructable ACL is a prerequisite, as is normal or correctable lower-limb alignment. Significant generalised osteoarthritis in the surrounding compartments is a relative contraindication — not because the procedure cannot be done, but because the structural conditions needed for the graft to bed in and bear load properly are no longer present. Where malalignment is the underlying cause of uneven loading, a corrective osteotomy may need to be performed either before or at the same sitting.

When a concurrent meniscal tear or ligamentous instability is present, it should be addressed in the same operation. Leaving instability uncorrected transfers abnormal shear forces to the graft during healing, which undermines the repair before it has consolidated.

High-demand patients — those in pivoting sports, distance running, or physically intensive occupations — tend to benefit most, precisely because hyaline cartilage tolerates sustained, repetitive loading in ways that fibrocartilage does not. Marrow-stimulation approaches have historically been used for smaller defects, but evidence shows the fibrocartilage they produce deteriorates under repeated load, particularly in active knees, which is why their role has narrowed considerably in modern practice.

Age above 40–50 and diffuse arthritic change are relative rather than absolute bars. Clinical context, defect characteristics, and activity level all factor into the decision; a consultant assessment is needed to weigh them accurately.

How defect size drives the choice of technique

Defect area is the single most reliable variable when choosing between these techniques — more so than age, activity level, or joint location. The approximate size thresholds below guide rather than dictate; clinical context always modifies the decision, and a consultant review is needed to confirm which pathway applies.

Under approximately 2 cm²: OATS — a single plug, typically 8–10 mm in diameter — is usually sufficient. The defect is compact enough that one well-seated cylinder restores the surface without requiring multiple harvest sites.

Between roughly 2 cm² and 4 cm²: this is mosaicplasty territory. Several smaller plugs, arranged side by side, allow the surgeon to tile a wider damaged zone that a single plug cannot cover. Donor supply from the same knee remains manageable within this range.

Above 4 cm²: autograft harvest from one knee cannot fill the defect adequately without creating meaningful donor-site damage. Cell-based options — MACI or first-generation ACI — or osteochondral allograft (cadaver tissue, sized to match) are generally preferred at this scale.

One further threshold matters for counselling. The SUMMIT trial found that defects of 3 cm² or larger had improved KOOS pain and function scores with MACI compared with microfracture at both two and five years. Although the trial compared MACI against microfracture rather than against mosaicplasty directly, the finding supports caution about mosaicplasty above the 3 cm² mark — particularly where the surface area approaches the upper limit of what autograft can reasonably cover.

Pre-operative MRI, including cartilage-specific sequences, provides the defect measurements that make these judgements reliable and reproducible.

What the evidence says about long-term durability

Ten-year follow-up data provides the clearest picture of how these procedures hold up under real-world conditions — and the evidence contains both reassuring findings and a nuance worth discussing before surgery.

The strongest head-to-head reference point is the prospective RCT by Gudas et al. in young athletes. At ten years, OATS produced significantly superior clinical outcomes compared with microfracture, while microfracture results deteriorated progressively over the same period. That pattern of decline is consistent with what is known about fibrocartilage — the repair tissue microfracture generates — which lacks the stiffness and wear resistance of native hyaline cartilage and tends to break down under repeated high-load use.

Pareek et al.'s 2016 systematic review confirmed durability across a broader evidence base: IKDC and Lysholm scores remained significantly improved from pre-operative baseline at the ten-year mark. These are clinically meaningful, validated measures of pain and knee function, and their sustained improvement is the core of the long-term case for the procedure.

The same review identified an important nuance: Tegner activity scores — which reflect return to sport specifically — did not consistently recover to pre-injury levels. Patients reported substantially less pain and better day-to-day function, but not every patient returned to the same sport at the same intensity. That distinction matters when discussing expectations before surgery.

Activity demand also moderates who benefits most. In mixed-activity general populations, Lim et al. found no statistically significant difference between OATS, microfracture, and ACI. The divergence between techniques becomes most apparent under high-impact and pivoting conditions — which is precisely where hyaline cartilage's mechanical advantages over fibrocartilage are stress-tested most directly. NICE guidance (HTG463) supports mosaicplasty for appropriately selected patients, acknowledging that the procedure sits within an established evidence base rather than at its frontier.

Recovery timeline and returning to sport

For the first six weeks, weight through the operated leg is restricted to toe-touch or partial loading, with crutches supporting most patients until around week four to six as the graft begins integrating. A brief period of donor-site discomfort — from the harvest site on the same knee — is common in these early weeks and generally settles without complication.

Months 2–3: once crutches are discontinued, rehabilitation shifts to progressive weight-bearing, stationary cycling, and hydrotherapy where available. Range of motion continues to improve, and muscle bulk lost during protected loading begins to recover with guided physiotherapy.

Months 3–6: functional strengthening, proprioception training, and early sport-specific conditioning form the focus. For those in manual occupations, return to modified duties is often feasible in this window, subject to the physical demands of the role.

6–9 months: return to pivoting or contact sport is not time-gated alone — it depends on limb symmetry index testing, which objectively compares strength and hop performance between the operated and unaffected leg. Clearance follows adequate symmetry thresholds, not the calendar.

As with any cartilage restoration procedure, full return to pre-injury sport level is not universal; some patients recover pain and function substantially while their sport-specific activity settles at a somewhat lower intensity. A realistic discussion of expectations before surgery is part of good pre-operative planning.

How to access OATS or mosaicplasty in Lincolnshire

Getting from a knee symptom to an OATS or mosaicplasty procedure requires understanding two separate pathways — and knowing which applies before assuming either.

The NHS position

The NHS does not directly commission OATS or mosaicplasty. The sole NHS-funded route for surgical cartilage repair is NICE Technology Appraisal TA477, which authorises ACI and MACI only, delivered at a small number of designated tertiary centres: Robert Jones and Agnes Hunt Orthopaedic Hospital (RJAH) in Oswestry, the Royal National Orthopaedic Hospital (RNOH) at Stanmore, and University Hospital Southampton. None is in Lincolnshire. Patients meeting TA477 criteria — typically defects of 3 cm² or larger — can be referred along this route following specialist assessment; those with smaller defects, or who specifically want an autograft technique, fall outside it. NHS orthopaedic waiting times across the East Midlands currently average approximately 30 to 50 weeks for initial assessment.

The private route

Patients seeking OATS or mosaicplasty directly, or those outside TA477 criteria, will generally need to access it privately. Locally, the Lincolnshire Knee Clinic — based in Sleaford (NG34), with a consultation and diagnostics site in Grantham (NG31) — offers consultant-led cartilage assessment without requiring a GP referral. Waiting times on the private pathway vary and change; patients should confirm current timings directly with the clinic rather than relying on general estimates.

A practical first step

Whatever route a patient is considering, a cartilage-specific MRI is the essential starting point. Characterising defect size, grade, and the state of surrounding cartilage determines whether OATS, mosaicplasty, MACI, or another approach is appropriate — without it, no pathway can be planned reliably. Patients approaching a GP can ask specifically for an orthopaedic or sports medicine referral alongside a request for cartilage-protocol MRI imaging; that will support the referral whether the eventual appointment is NHS or private.